{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:43:56Z","timestamp":1791470636102,"version":"4.3.4"},"reference-count":192,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.xphs.2018.11.029","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T05:26:46Z","timestamp":1542864406000},"page":"1366-1377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins"],"prefix":"10.1016","volume":"108","author":[{"given":"Qun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.11.029_bib1","series-title":"Essentials of Glycobiology","year":"2015"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/07388551.2013.793649","article-title":"Glycosylation: impact, control and improvement during therapeutic protein production","volume":"34","author":"Costa","year":"2014","journal-title":"Crit Rev Biotechnol"},{"issue":"11","key":"10.1016\/j.xphs.2018.11.029_bib3","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1158\/0008-5472.CAN-18-0032","article-title":"Glycosylation of recombinant anticancer therapeutics in different expression systems with emerging technologies","volume":"78","author":"Nadeem","year":"2018","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.xphs.2018.11.029_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nbt1252","article-title":"Post-translational modifications in the context of therapeutic proteins","volume":"24","author":"Walsh","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.xphs.2018.11.029_bib5","series-title":"Essentials of Glycobiology","first-page":"99","article-title":"N-glycans","author":"Stanley","year":"2015"},{"key":"10.1016\/j.xphs.2018.11.029_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.54.070185.003215","article-title":"Assembly of asparagine-linked oligosaccharides","volume":"54","author":"Kornfeld","year":"1985","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib7","doi-asserted-by":"crossref","first-page":"91r","DOI":"10.1093\/glycob\/cwj099","article-title":"Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems","volume":"16","author":"Weerapana","year":"2006","journal-title":"Glycobiology"},{"issue":"41","key":"10.1016\/j.xphs.2018.11.029_bib8","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1002\/anie.200601645","article-title":"Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases","volume":"45","author":"Lehle","year":"2006","journal-title":"Angew Chem Int Ed Engl"},{"issue":"42","key":"10.1016\/j.xphs.2018.11.029_bib9","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.1021\/ja306068g","article-title":"Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis","volume":"134","author":"Bowden","year":"2012","journal-title":"J\u00a0Am Chem Soc"},{"issue":"10","key":"10.1016\/j.xphs.2018.11.029_bib10","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/S0021-9258(18)62222-7","article-title":"The structure of the glycopeptide of human gamma G myeloma proteins","volume":"246","author":"Kornfeld","year":"1971","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","article-title":"Fc glycans of therapeutic antibodies as critical quality attributes","volume":"25","author":"Reusch","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.xphs.2018.11.029_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"10.1016\/j.xphs.2018.11.029_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.tibtech.2016.02.013","article-title":"N-glycosylation design and control of therapeutic monoclonal antibodies","volume":"34","author":"Sha","year":"2016","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/glycob\/cwl057","article-title":"Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types","volume":"17","author":"Kanda","year":"2007","journal-title":"Glycobiology"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib15","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.4049\/jimmunol.160.7.3393","article-title":"Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells","volume":"160","author":"Wright","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/bit.21598","article-title":"Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function","volume":"99","author":"Zhou","year":"2008","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/mabs.20737","article-title":"Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans","volume":"4","author":"Yu","year":"2012","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/glycob\/cwm015","article-title":"N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits","volume":"17","author":"Jongen","year":"2007","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbiotec.2005.01.001","article-title":"Effect of genetic background on glycosylation heterogeneity in human antithrombin produced in the mammary gland of transgenic goats","volume":"117","author":"Zhou","year":"2005","journal-title":"J\u00a0Biotechnol"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/498652","article-title":"The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy","volume":"77","author":"Du","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib21","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/BF01053197","article-title":"Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialyltransferase","volume":"13","author":"Morimoto","year":"1996","journal-title":"Glycoconj J"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib22","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1371\/journal.pone.0000713","article-title":"Systems analysis of N-glycan processing in mammalian cells","volume":"2","author":"Hossler","year":"2007","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.xphs.2018.11.029_bib23","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.80.21.6632","article-title":"Biological significance of carbohydrate chains on monoclonal antibodies","volume":"80","author":"Nose","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib24","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1084\/jem.180.3.1087","article-title":"Effect of altered CH2-associated carbohydrate structure on the functional properties and in\u00a0vivo fate of chimeric mouse-human immunoglobulin G1","volume":"180","author":"Wright","year":"1994","journal-title":"J\u00a0Exp Med"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tips.2009.04.007","article-title":"Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action","volume":"30","author":"Jefferis","year":"2009","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: the intravenous IgG paradox","volume":"204","author":"Nimmerjahn","year":"2007","journal-title":"J\u00a0Exp Med"},{"issue":"23","key":"10.1016\/j.xphs.2018.11.029_bib27","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1021\/bi9517704","article-title":"Influence of the carbohydrate moiety on the stability of glycoproteins","volume":"35","author":"Wang","year":"1996","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tibs.2006.01.003","article-title":"N-linked oligosaccharides as outfitters for glycoprotein folding, form and function","volume":"31","author":"Mitra","year":"2006","journal-title":"Trends Biochem Sci"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib29","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jps.20319","article-title":"Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins","volume":"94","author":"Sinclair","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.21504","article-title":"Effects of glycosylation on the stability of protein pharmaceuticals","volume":"98","author":"Sola","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib32","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jps.24444","article-title":"Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins","volume":"104","author":"Liu","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"issue":"Suppl 3","key":"10.1016\/j.xphs.2018.11.029_bib33","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0959-8049(94)00401-3","article-title":"Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency","volume":"30A","author":"Nissen","year":"1994","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1189\/jlb.0803378","article-title":"The significance of carbohydrates on G-CSF: differential sensitivity of G-CSFs to human neutrophil elastase degradation","volume":"75","author":"Carter","year":"2004","journal-title":"J\u00a0Leukoc Biol"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biologicals.2003.12.002","article-title":"Human serum inactivates non-glycosylated but not glycosylated granulocyte colony stimulating factor by a protease dependent mechanism: significance of carbohydrates on the glycosylated molecule","volume":"32","author":"Carter","year":"2004","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1432-1327.1999.00427.x","article-title":"Site-directed removal of N-glycosylation sites in human gastric lipase","volume":"262","author":"Wicker-Planquart","year":"1999","journal-title":"Eur J Biochem"},{"issue":"15","key":"10.1016\/j.xphs.2018.11.029_bib37","doi-asserted-by":"crossref","first-page":"9778","DOI":"10.1016\/S0021-9258(18)92888-7","article-title":"Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin","volume":"266","author":"Grinnell","year":"1991","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/bi00167a003","article-title":"Glycoforms modify the dynamic stability and functional activity of an enzyme","volume":"33","author":"Rudd","year":"1994","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.01.153","article-title":"Glycosylation of onconase increases its conformational stability and toxicity for cancer cells","volume":"315","author":"Kim","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 1","key":"10.1016\/j.xphs.2018.11.029_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/bj3080009","article-title":"N-glycosylation of human interferon-gamma: glycans at Asn-25 are critical for protease resistance","volume":"308","author":"Sareneva","year":"1995","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10715769709065769","article-title":"Effect of active oxygen radicals on protein and carbohydrate moieties of recombinant human erythropoietin","volume":"27","author":"Uchida","year":"1997","journal-title":"Free Radic Res"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib42","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/A:1011974512425","article-title":"Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta)","volume":"15","author":"Runkel","year":"1998","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jps.2600840108","article-title":"Physical stabilization of insulin by glycosylation","volume":"84","author":"Baudys","year":"1995","journal-title":"J\u00a0Pharm Sci"},{"issue":"Pt 3","key":"10.1016\/j.xphs.2018.11.029_bib44","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1042\/bj3320789","article-title":"Human alpha-galactosidase A: glycosylation site 3 is essential for enzyme solubility","volume":"332","author":"Ioannou","year":"1998","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1210\/endo-112-4-1331","article-title":"Glycosylation of thyroid-stimulating hormone in pituitary tumor cells: influence of high mannose oligosaccharide units on subunit aggregation, combination, and intracellular degradation","volume":"112","author":"Weintraub","year":"1983","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/oxfordjournals.jbchem.a123961","article-title":"Heat-induced aggregation of recombinant erythropoietin in the intact and deglycosylated states as monitored by gel permeation chromatography combined with a low-angle laser light scattering technique","volume":"112","author":"Endo","year":"1992","journal-title":"J\u00a0Biochem"},{"issue":"11","key":"10.1016\/j.xphs.2018.11.029_bib47","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s000180050248","article-title":"The structure of human interferon-beta: implications for activity","volume":"54","author":"Karpusas","year":"1998","journal-title":"Cell Mol Life Sci"},{"issue":"30","key":"10.1016\/j.xphs.2018.11.029_bib48","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1016\/S0021-9258(18)47838-6","article-title":"Structure of the carbohydrate moiety of human interferon-beta secreted by a recombinant Chinese hamster ovary cell line","volume":"262","author":"Conradt","year":"1987","journal-title":"J\u00a0Biol Chem"},{"issue":"34","key":"10.1016\/j.xphs.2018.11.029_bib49","doi-asserted-by":"crossref","first-page":"23022","DOI":"10.1016\/S0021-9258(18)54457-4","article-title":"The effect of carbohydrate on the structure and stability of erythropoietin","volume":"266","author":"Narhi","year":"1991","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4165(96)00143-2","article-title":"Effect of glycosylation on the stability of alpha1-antitrypsin toward urea denaturation and thermal deactivation","volume":"1335","author":"Kwon","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 3","key":"10.1016\/j.xphs.2018.11.029_bib51","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0959-8049(94)00403-X","article-title":"Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim)","volume":"30A","author":"Ono","year":"1994","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-5793(92)80709-P","article-title":"Effects of glycosylation on protein conformation and amide proton exchange rates in RNase B","volume":"307","author":"Joao","year":"1992","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1432-1033.1993.tb18370.x","article-title":"Effects of glycosylation on protein structure and dynamics in ribonuclease B and some of its individual glycoforms","volume":"218","author":"Joao","year":"1993","journal-title":"Eur J Biochem"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib54","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1021\/bi9718548","article-title":"Mobilities of the inner three core residues and the Man(alpha 1\u20136) branch of the glycan at Asn78 of the alpha-subunit of human chorionic gonadotropin are restricted by the protein","volume":"37","author":"van Zuylen","year":"1998","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib55","first-page":"128","article-title":"Effect of glycosylation at Asn302 of pro-urokinase on its stability in culture supernatant","volume":"21","author":"Yang","year":"2006","journal-title":"Chin Med Sci J"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib56","doi-asserted-by":"crossref","first-page":"e96967","DOI":"10.1371\/journal.pone.0096967","article-title":"Glycoengineering of interferon-beta 1a improves its biophysical and pharmacokinetic properties","volume":"9","author":"Song","year":"2014","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.xphs.2018.11.029_bib57","doi-asserted-by":"crossref","first-page":"12827","DOI":"10.1074\/jbc.M313173200","article-title":"N-glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I","volume":"279","author":"Wujek","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"20","key":"10.1016\/j.xphs.2018.11.029_bib58","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1073\/pnas.86.20.7819","article-title":"Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells","volume":"86","author":"Takeuchi","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib59","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1432-1033.1990.tb15417.x","article-title":"The role of carbohydrate in recombinant human erythropoietin","volume":"188","author":"Tsuda","year":"1990","journal-title":"Eur J Biochem"},{"issue":"49","key":"10.1016\/j.xphs.2018.11.029_bib60","doi-asserted-by":"crossref","first-page":"45539","DOI":"10.1074\/jbc.M107478200","article-title":"Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding","volume":"276","author":"Mimura","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib61","doi-asserted-by":"crossref","first-page":"e0143520","DOI":"10.1371\/journal.pone.0143520","article-title":"Multi-angle effector function analysis of human monoclonal IgG glycovariants","volume":"10","author":"Dashivets","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib62","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1074\/jbc.M111.297697","article-title":"Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc","volume":"287","author":"Latypov","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib63","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/jps.23975","article-title":"Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp\/Gln residues at site Asn 297","volume":"103","author":"Alsenaidy","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib64","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4161\/mabs.3.6.17922","article-title":"The impact of glycosylation on monoclonal antibody conformation and stability","volume":"3","author":"Zheng","year":"2011","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4161\/mabs.28588","article-title":"Influence of glycosylation pattern on the molecular properties of monoclonal antibodies","volume":"6","author":"Zheng","year":"2014","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbrc.2006.01.030","article-title":"Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain","volume":"341","author":"Raju","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/bp070118k","article-title":"Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain","volume":"23","author":"Raju","year":"2007","journal-title":"Biotechnol Prog"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib68","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.molimm.2007.07.012","article-title":"Structural effect of deglycosylation and methionine oxidation on a recombinant monoclonal antibody","volume":"45","author":"Liu","year":"2008","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.xphs.2015.10.014","article-title":"Correlating the impact of well-defined oligosaccharide structures on physical stability profiles of IgG1-Fc glycoforms","volume":"105","author":"More","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib70","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The emerging importance of IgG Fab glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xphs.2018.11.029_bib71","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2018.00740","article-title":"Variable domain N-linked glycans acquired during antigen-specific immune responses can contribute to immunoglobulin G antibody stability","volume":"9","author":"van de Bovenkamp","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib72","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-2836(02)01250-0","article-title":"Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity","volume":"325","author":"Krapp","year":"2003","journal-title":"J\u00a0Mol Biol"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib73","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbagen.2005.10.002","article-title":"Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy","volume":"1760","author":"Yamaguchi","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib74","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1074\/mcp.M900540-MCP200","article-title":"Post-translational modifications differentially affect IgG1 conformation and receptor binding","volume":"9","author":"Houde","year":"2010","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib75","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/cb300130k","article-title":"Revisiting the role of glycosylation in the structure of human IgG Fc","volume":"7","author":"Borrok","year":"2012","journal-title":"ACS Chem Biol"},{"issue":"24","key":"10.1016\/j.xphs.2018.11.029_bib76","doi-asserted-by":"crossref","first-page":"9868","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"10.1016\/j.xphs.2018.11.029_bib77","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1021\/ja4014375","article-title":"Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies","volume":"135","author":"Yu","year":"2013","journal-title":"J\u00a0Am Chem Soc"},{"issue":"18","key":"10.1016\/j.xphs.2018.11.029_bib78","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.jmb.2014.07.006","article-title":"Structural characterization of anti-inflammatory immunoglobulin G Fc proteins","volume":"426","author":"Ahmed","year":"2014","journal-title":"J\u00a0Mol Biol"},{"issue":"31","key":"10.1016\/j.xphs.2018.11.029_bib79","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1073\/pnas.1108455108","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib80","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1021\/bi9621472","article-title":"Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides","volume":"36","author":"Wormald","year":"1997","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib81","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/bi00512a001","article-title":"Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution","volume":"20","author":"Deisenhofer","year":"1981","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nchembio.511","article-title":"NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic","volume":"7","author":"Barb","year":"2011","journal-title":"Nat Chem Biol"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib83","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.str.2015.06.015","article-title":"The structural role of antibody N-glycosylation in receptor interactions","volume":"23","author":"Subedi","year":"2015","journal-title":"Structure"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bip.22030","article-title":"N-glycosylation of enhanced aromatic sequons to increase glycoprotein stability","volume":"98","author":"Price","year":"2012","journal-title":"Biopolymers"},{"issue":"34","key":"10.1016\/j.xphs.2018.11.029_bib85","doi-asserted-by":"crossref","first-page":"14127","DOI":"10.1073\/pnas.1105880108","article-title":"Glycosylation of the enhanced aromatic sequon is similarly stabilizing in three distinct reverse turn contexts","volume":"108","author":"Price","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6017","key":"10.1016\/j.xphs.2018.11.029_bib86","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.1198461","article-title":"Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns","volume":"331","author":"Culyba","year":"2011","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib87","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acschembio.5b01035","article-title":"Stabilizing the CH2 domain of an antibody by engineering in an enhanced aromatic sequon","volume":"11","author":"Chen","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/19420862.2015.1112477","article-title":"Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab","volume":"8","author":"Courtois","year":"2016","journal-title":"MAbs"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib89","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/protein\/gzq037","article-title":"Structure-based engineering of a monoclonal antibody for improved solubility","volume":"23","author":"Wu","year":"2010","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.xphs.2018.11.029_bib90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2091-15-16","article-title":"Chemical glycosylation of cytochrome c improves physical and chemical protein stability","volume":"15","author":"Delgado","year":"2014","journal-title":"BMC Biochem"},{"issue":"17","key":"10.1016\/j.xphs.2018.11.029_bib91","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1021\/ja300893t","article-title":"Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation","volume":"134","author":"Styslinger","year":"2012","journal-title":"J\u00a0Am Chem Soc"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib92","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/bit.20933","article-title":"Engineering of protein thermodynamic, kinetic, and colloidal stability: chemical Glycosylation with monofunctionally activated glycans","volume":"94","author":"Sola","year":"2006","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.xphs.2018.11.029_bib93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.copbio.2014.06.010","article-title":"The choice of mammalian cell host and possibilities for glycosylation engineering","volume":"30","author":"Butler","year":"2014","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib94","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/btpr.92","article-title":"N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG","volume":"25","author":"van Berkel","year":"2009","journal-title":"Biotechnol Prog"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ab.2004.07.028","article-title":"N-linked oligosaccharide analysis of glycoprotein bands from isoelectric focusing gels","volume":"335","author":"Zhou","year":"2004","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pep.2009.12.015","article-title":"Transient expression of an IL-23R extracellular domain Fc fusion protein in CHO vs. HEK cells results in improved plasma exposure","volume":"71","author":"Suen","year":"2010","journal-title":"Protein Expr Purif"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib97","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11095-012-0921-3","article-title":"The impact of glycosylation on the pharmacokinetics of a TNFR2:Fc fusion protein expressed in Glycoengineered Pichia Pastoris","volume":"30","author":"Liu","year":"2013","journal-title":"Pharm Res"},{"issue":"17","key":"10.1016\/j.xphs.2018.11.029_bib98","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1016\/S0021-9258(20)79761-9","article-title":"The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins","volume":"249","author":"Hudgin","year":"1974","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/physrev.1995.75.3.591","article-title":"The asialoglycoprotein receptor: relationships between structure, function, and expression","volume":"75","author":"Stockert","year":"1995","journal-title":"Physiol Rev"},{"issue":"2 Pt 2","key":"10.1016\/j.xphs.2018.11.029_bib100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0092-8674(80)90371-2","article-title":"Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes","volume":"22","author":"Baenziger","year":"1980","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib101","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1074\/jbc.M210612200","article-title":"Rapid clearance of sialylated glycoproteins by the asialoglycoprotein receptor","volume":"278","author":"Park","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib102","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.bmc.2008.03.017","article-title":"Trivalent, Gal\/GalNAc-containing ligands designed for the asialoglycoprotein receptor","volume":"16","author":"Khorev","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"47","key":"10.1016\/j.xphs.2018.11.029_bib103","doi-asserted-by":"crossref","first-page":"17125","DOI":"10.1073\/pnas.0508537102","article-title":"The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc","volume":"102","author":"Park","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.1016\/j.xphs.2018.11.029_bib104","doi-asserted-by":"crossref","first-page":"18429","DOI":"10.1016\/S0021-9258(17)44770-3","article-title":"Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat heptocytes","volume":"265","author":"Rice","year":"1990","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib106","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj2450705","article-title":"Isolation and characterization of a mannose-specific endocytosis receptor from rabbit alveolar macrophages","volume":"245","author":"Lennartz","year":"1987","journal-title":"Biochem J"},{"issue":"21","key":"10.1016\/j.xphs.2018.11.029_bib107","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1016\/S0021-9258(19)38325-5","article-title":"Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains","volume":"265","author":"Taylor","year":"1990","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib108","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9258(18)54164-8","article-title":"Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor","volume":"268","author":"Taylor","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"5561","key":"10.1016\/j.xphs.2018.11.029_bib109","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1069540","article-title":"Mannose receptor-mediated regulation of serum glycoprotein homeostasis","volume":"295","author":"Lee","year":"2002","journal-title":"Science"},{"issue":"36","key":"10.1016\/j.xphs.2018.11.029_bib110","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1074\/jbc.M116.738948","article-title":"Functional consequences of mannose and asialoglycoprotein receptor ablation","volume":"291","author":"Mi","year":"2016","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib111","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/bj1940733","article-title":"Studies in\u00a0vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat","volume":"194","author":"Morrone","year":"1981","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib112","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1538-7836.2005.01389.x","article-title":"The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor","volume":"3","author":"Bovenschen","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib113","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0038-1647041","article-title":"The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator","volume":"60","author":"Hotchkiss","year":"1988","journal-title":"Thromb Haemost"},{"issue":"1-2","key":"10.1016\/j.xphs.2018.11.029_bib114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1432-1327.1998.2510107.x","article-title":"Role of carbohydrate and protein in the binding of tissue-type plasminogen activator to the human mannose receptor","volume":"251","author":"Noorman","year":"1998","journal-title":"Eur J Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-4165(03)00141-7","article-title":"Monitoring biodistribution of glycoproteins with modified sugar chains","volume":"1622","author":"Takamatsu","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib116","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood.V73.1.84.84","article-title":"Survival of recombinant erythropoietin in the circulation: the role of carbohydrates","volume":"73","author":"Fukuda","year":"1989","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib117","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V77.12.2624.2624","article-title":"The importance of N- and O-linked oligosaccharides for the biosynthesis and in\u00a0vitro and in\u00a0vivo biologic activities of erythropoietin","volume":"77","author":"Wasley","year":"1991","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.xphs.2018.11.029_bib118","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1073\/pnas.92.20.9062","article-title":"Subunit-specific functions of N-linked oligosaccharides in human thyrotropin: role of terminal residues of alpha- and beta-subunit oligosaccharides in metabolic clearance and bioactivity","volume":"92","author":"Szkudlinski","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2018.11.029_bib119","first-page":"3","article-title":"Trafficking of asialoglycoproteins and the asialoglycoprotein receptor","volume":"4","author":"Schwartz","year":"1991","journal-title":"Targeted Diagn Ther"},{"key":"10.1016\/j.xphs.2018.11.029_bib120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1146\/annurev-biochem-062917-012644","article-title":"Regulation of clathrin-mediated endocytosis","volume":"87","author":"Mettlen","year":"2018","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib121","doi-asserted-by":"crossref","first-page":"1r","DOI":"10.1093\/glycob\/cwi041","article-title":"Lysosomal metabolism of glycoproteins","volume":"15","author":"Winchester","year":"2005","journal-title":"Glycobiology"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib122","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0304-4165(81)90474-8","article-title":"Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation","volume":"673","author":"Furbish","year":"1981","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib123","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0006-291X(78)91456-0","article-title":"The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells","volume":"81","author":"Furbish","year":"1978","journal-title":"Biochem Biophys Res Commun"},{"issue":"41","key":"10.1016\/j.xphs.2018.11.029_bib124","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0607053103","article-title":"Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors","volume":"103","author":"Sly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-2002-32661","article-title":"Preclinical pharmacology of albumin-free B-domain deleted recombinant factor VIII","volume":"28","author":"Brinkhous","year":"2002","journal-title":"Semin Thromb Hemost"},{"issue":"41","key":"10.1016\/j.xphs.2018.11.029_bib126","doi-asserted-by":"crossref","first-page":"9871","DOI":"10.1021\/bi00156a003","article-title":"Role of glycosylation on the secretion and biological activity of erythropoietin","volume":"31","author":"Delorme","year":"1992","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib127","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1002\/jps.23320","article-title":"The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin","volume":"101","author":"Liu","year":"2012","journal-title":"J\u00a0Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib128","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.4049\/jimmunol.143.8.2595","article-title":"Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region","volume":"143","author":"Tao","year":"1989","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biologicals.2011.06.002","article-title":"Pharmacokinetics of IgG1 monoclonal antibodies produced in humanized Pichia pastoris with specific glycoforms: a comparative study with CHO produced materials","volume":"39","author":"Liu","year":"2011","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.xphs.2018.11.029_bib130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4161\/mabs.26436","article-title":"Effects of altered FcgammaR binding on antibody pharmacokinetics in cynomolgus monkeys","volume":"5","author":"Leabman","year":"2013","journal-title":"MAbs"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib131","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1074\/jbc.M116.748525","article-title":"Engineering an IgG scaffold lacking effector function with optimized developability","volume":"292","author":"Jacobsen","year":"2017","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib132","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biologicals.2007.05.003","article-title":"Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice","volume":"36","author":"Millward","year":"2008","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib133","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4049\/jimmunol.162.4.2162","article-title":"Position effects of variable region carbohydrate on the affinity and in\u00a0vivo behavior of an anti-(1-->6) dextran antibody","volume":"162","author":"Coloma","year":"1999","journal-title":"J\u00a0Immunol"},{"issue":"13","key":"10.1016\/j.xphs.2018.11.029_bib134","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0161-5890(95)00078-S","article-title":"Glycosylation of the variable region of immunoglobulin G\u2013site specific maturation of the sugar chains","volume":"32","author":"Endo","year":"1995","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.xphs.2018.11.029_bib135","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1158\/0008-5472.CAN-09-3704","article-title":"Superior in\u00a0vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer","volume":"70","author":"Junttila","year":"2010","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4161\/mabs.2.3.11788","article-title":"Stability of IgG isotypes in serum","volume":"2","author":"Correia","year":"2010","journal-title":"MAbs"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib137","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/mabs.20450","article-title":"Increased serum clearance of oligomannose species present on a human IgG1 molecule","volume":"4","author":"Alessandri","year":"2012","journal-title":"MAbs"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib138","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/glycob\/cwr027","article-title":"High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans","volume":"21","author":"Goetze","year":"2011","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.xphs.2018.11.029_bib139","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.4049\/jimmunol.163.10.5427","article-title":"Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells","volume":"163","author":"Dong","year":"1999","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib140","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1074\/jbc.272.9.5668","article-title":"Mechanism of Ca2+ and monosaccharide binding to a C-type carbohydrate-recognition domain of the macrophage mannose receptor","volume":"272","author":"Mullin","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.xphs.2018.11.029_bib141","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1073\/pnas.1416694112","article-title":"Glycosylation profiles determine extravasation and disease-targeting properties of armed antibodies","volume":"112","author":"Venetz","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib142","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/glycob\/cwl053","article-title":"Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy","volume":"17","author":"Kogelberg","year":"2007","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib143","doi-asserted-by":"crossref","first-page":"e63530","DOI":"10.1371\/journal.pone.0063530","article-title":"A\u00a0bispecific protein capable of engaging CTLA-4 and MHCII protects non-obese diabetic mice from autoimmune diabetes","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib144","first-page":"159","article-title":"Immunomodulation by LFA3TIP, an LFA-3\/IgG1 fusion protein: cell line dependent glycosylation effects on pharmacokinetics and pharmacodynamic markers","volume":"2","author":"Meier","year":"1995","journal-title":"Ther Immunol"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/bit.260470314","article-title":"Fluorophore-labeled carbohydrate analysis of immunoglobulin fusion proteins: correlation of oligosaccharide content with in\u00a0vivo clearance profile","volume":"47","author":"Flesher","year":"1995","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib146","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biologicals.2007.05.004","article-title":"Characterization of a complex glycoprotein whose variable metabolic clearance in humans is dependent on terminal N-acetylglucosamine content","volume":"36","author":"Keck","year":"2008","journal-title":"Biologicals"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib147","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/glycob\/cwm017","article-title":"Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys","volume":"17","author":"Jones","year":"2007","journal-title":"Glycobiology"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib148","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/bc400365a","article-title":"Glycan structure determinants for cation-independent mannose 6-phosphate receptor binding and cellular uptake of a recombinant protein","volume":"24","author":"Zhou","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib149","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt799","article-title":"Enhancement of therapeutic protein in\u00a0vivo activities through glycoengineering","volume":"21","author":"Elliott","year":"2003","journal-title":"Nat Biotechnol"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib150","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.exphem.2004.08.004","article-title":"Control of rHuEPO biological activity: the role of carbohydrate","volume":"32","author":"Elliott","year":"2004","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib151","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1038\/s41598-018-22456-w","article-title":"Glyco-engineered long acting FGF21 variant with optimal pharmaceutical and pharmacokinetic properties to enable weekly to twice monthly subcutaneous dosing","volume":"8","author":"Weng","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib152","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2011-02-336172","article-title":"Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide","volume":"118","author":"Ostergaard","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib153","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1210\/en.2012-2010","article-title":"Carbohydrate-mediated polyethylene glycol conjugation of TSH improves its pharmacological properties","volume":"154","author":"Park","year":"2013","journal-title":"Endocrinology"},{"issue":"Suppl 6","key":"10.1016\/j.xphs.2018.11.029_bib154","doi-asserted-by":"crossref","first-page":"vi3","DOI":"10.1093\/ndt\/gfh1092","article-title":"Factors influencing the immunogenicity of therapeutic proteins","volume":"20","author":"Schellekens","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib155","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jphp.12810","article-title":"Immunogenicity assessment during the development of protein therapeutics","volume":"70","author":"Rosenberg","year":"2018","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib156","first-page":"3161","article-title":"The importance of handling high-value biologicals: physico-chemical instability and immunogenicity of monoclonal antibodies","volume":"15","author":"Laptos","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.xphs.2018.11.029_bib157","first-page":"6262383","article-title":"Emerging technologies and generic assays for the detection of anti-drug antibodies","volume":"2016","author":"Partridge","year":"2016","journal-title":"J\u00a0Immunol Res"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib158","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1208\/s12248-016-9878-1","article-title":"Pre-existing antibody: biotherapeutic modality-based review","volume":"18","author":"Gorovits","year":"2016","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2018.11.029_bib159","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","article-title":"The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance","volume":"1780","author":"Macher","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nbt.1651","article-title":"Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins","volume":"28","author":"Ghaderi","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"15","key":"10.1016\/j.xphs.2018.11.029_bib161","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1074\/jbc.275.15.11451","article-title":"Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens","volume":"275","author":"van Ree","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"3-4","key":"10.1016\/j.xphs.2018.11.029_bib162","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10719-015-9590-x","article-title":"Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human beta1,4-galactosyltransferase and human CTLA4Ig","volume":"32","author":"Kang","year":"2015","journal-title":"Glycoconj J"},{"issue":"21","key":"10.1016\/j.xphs.2018.11.029_bib163","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1073\/pnas.86.21.8227","article-title":"Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer","volume":"86","author":"Larsen","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.xphs.2018.11.029_bib164","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/abio.1997.2036","article-title":"Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose","volume":"247","author":"Sheeley","year":"1997","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1016\/j.xphs.2018.11.029_bib165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib166","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/glycob\/cwm137","article-title":"A\u00a0plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits","volume":"18","author":"Jin","year":"2008","journal-title":"Glycobiology"},{"issue":"11","key":"10.1016\/j.xphs.2018.11.029_bib167","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nbt1110-1153","article-title":"Chinese hamster ovary cells can produce galactose-alpha-1,3-galactose antigens on proteins","volume":"28","author":"Bosques","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"52","key":"10.1016\/j.xphs.2018.11.029_bib168","doi-asserted-by":"crossref","first-page":"50469","DOI":"10.1074\/jbc.M208985200","article-title":"Characterization of sugar binding by the mannose receptor family member, Endo180","volume":"277","author":"East","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib169","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/glycob\/cwq193","article-title":"Survey of immune-related, mannose\/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities","volume":"21","author":"Lee","year":"2011","journal-title":"Glycobiology"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/protein\/gzr016","article-title":"Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin","volume":"24","author":"Holla","year":"2011","journal-title":"Protein engineering, design & selection: PEDS"},{"issue":"12","key":"10.1016\/j.xphs.2018.11.029_bib171","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1021\/ja511529x","article-title":"Langerin-heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments","volume":"137","author":"Munoz-Garcia","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.xphs.2018.11.029_bib172","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molimm.2012.09.012","article-title":"Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells","volume":"53","author":"Garcia-Vallejo","year":"2013","journal-title":"Mol Immunol"},{"issue":"8","key":"10.1016\/j.xphs.2018.11.029_bib173","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00262-006-0274-z","article-title":"The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma","volume":"56","author":"Saeland","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.xphs.2018.11.029_bib174","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jconrel.2013.12.011","article-title":"A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation","volume":"175","author":"Maglinao","year":"2014","journal-title":"Journal of Controlled Release"},{"issue":"41","key":"10.1016\/j.xphs.2018.11.029_bib175","doi-asserted-by":"crossref","first-page":"16933","DOI":"10.1074\/jbc.M117.800847","article-title":"Dectin-1 intracellular domain determines species-specific ligand spectrum by modulating receptor sensitivity","volume":"292","author":"Takano","year":"2017","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib176","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1074\/jbc.M511461200","article-title":"Ligands for the beta-glucan receptor, Dectin-1, assigned using \u201cdesigner\u201d microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides","volume":"281","author":"Palma","year":"2006","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.xphs.2018.11.029_bib177","doi-asserted-by":"crossref","first-page":"13402","DOI":"10.1074\/jbc.M117.799080","article-title":"Mechanism of pathogen recognition by human dectin-2","volume":"292","author":"Feinberg","year":"2017","journal-title":"J Biol Chem"},{"issue":"27","key":"10.1016\/j.xphs.2018.11.029_bib178","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1074\/jbc.M115.660613","article-title":"A novel mechanism for binding of galactose-terminated glycans by the C-type carbohydrate recognition domain in blood dendritic cell antigen 2","volume":"290","author":"Jegouzo","year":"2015","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.xphs.2018.11.029_bib179","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1073\/pnas.1612421114","article-title":"Rational design of adjuvants targeting the C-type lectin Mincle","volume":"114","author":"Decout","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib180","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clim.2013.09.006","article-title":"T-cell dependent immunogenicity of protein therapeutics: preclinical assessment and mitigation","volume":"149","author":"Jawa","year":"2013","journal-title":"Clin Immunol"},{"issue":"21","key":"10.1016\/j.xphs.2018.11.029_bib181","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1073\/pnas.0702120104","article-title":"A\u00a0role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes","volume":"104","author":"Dasgupta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.xphs.2018.11.029_bib182","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood-2016-11-750885","article-title":"Biological considerations of plasma-derived and recombinant factor VIII immunogenicity","volume":"129","author":"Lai","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib183","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1271\/bbb.110753","article-title":"Introducing site-specific glycosylation using protein engineering techniques reduces the immunogenicity of beta-lactoglobulin","volume":"76","author":"Tatsumi","year":"2012","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2018.11.029_bib184","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.0305480101","article-title":"Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"101","author":"Kakkis","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.xphs.2018.11.029_bib185","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/glycob\/cwn061","article-title":"Strategies for carbohydrate recognition by the mannose 6-phosphate receptors","volume":"18","author":"Dahms","year":"2008","journal-title":"Glycobiology"},{"issue":"48","key":"10.1016\/j.xphs.2018.11.029_bib186","doi-asserted-by":"crossref","first-page":"50336","DOI":"10.1074\/jbc.M409676200","article-title":"Conjugation of mannose 6-phosphate-containing oligosaccharides to acid alpha-glucosidase improves the clearance of glycogen in pompe mice","volume":"279","author":"Zhu","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"50","key":"10.1016\/j.xphs.2018.11.029_bib187","doi-asserted-by":"crossref","first-page":"35201","DOI":"10.1074\/jbc.M109.056119","article-title":"Glycan microarray analysis of P-type lectins reveals distinct phosphomannose glycan recognition","volume":"284","author":"Song","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2018.11.029_bib188","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/8904_2012_162","article-title":"Mannose 6-phosphate conjugation is not sufficient to allow induction of immune tolerance to phenylalanine ammonia-lyase in dogs","volume":"8","author":"Vera","year":"2013","journal-title":"JIMD Rep"},{"issue":"5","key":"10.1016\/j.xphs.2018.11.029_bib189","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.xphs.2018.11.029_bib190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.sbi.2015.06.003","article-title":"Recent insights into structures and functions of\u00a0C-type lectins in the immune system","volume":"34","author":"Drickamer","year":"2015","journal-title":"Curr Opin Struct Biol"},{"issue":"10","key":"10.1016\/j.xphs.2018.11.029_bib191","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"43","key":"10.1016\/j.xphs.2018.11.029_bib192","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1074\/jbc.RA118.004998","article-title":"CD16a with oligomannose-type N-glycans is the only \u201clow affinity\u201d Fc gamma receptor that binds the IgG crystallizable fragment with high affinity in vitro","volume":"293","author":"Subedi","year":"2018","journal-title":"J Biol Chem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918307366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918307366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:00:23Z","timestamp":1775278823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918307366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":192,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0022354918307366"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.11.029","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Mechanistic Impact of N-Glycosylation on Stability, Pharmacokinetics, and Immunogenicity of Therapeutic Proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}